Online video campaign ‘gives life’ to powerful Parkinson’s stories
Author: Geoffrey ChangPublished: 13 August 2015
Prep: Cook: Serves:
Sometimes a story needs more than just words on a page
A non-profit organisation has dedicated its 2015 campaign to raising international awareness of Parkinson’s through a collection of inspiring crowd-sourced videos.
Based in New York, the charity – My Angel My Hero – is appealing to those living with Parkinson’s to submit videos describing their personal journeys, the highs and the lows.
By encouraging people to share their stories, the campaign is aiming to inspire, empower and spread hope for others tackling the disease. The charity hopes to create a library of at least 200 online videos within the first year.
The charity has assembled a team of 25 volunteers from, video editors to development professionals to lawyers, to join in the humanitarian efforts.
Faizan Sheikh, founder of My Angel My Hero, said: “My Angel My Hero’s mission is to give life to stories through videos and films. We believe every moment is a story. Every story has a message. In phase one of our 2015 campaign, we’ll offer people affected by Parkinson’s the opportunity to be heard.”
The name of the campaign comes from a film that Sheikh made about a promising young dancer who is diagnosed with young onset Parkinson’s, a story inspired by real life events. He began to encourage others facing Parkinson’s to recount their experience on camera, giving rise to this latest online campaign.
Frankie Smith, a retired maths teacher diagnosed with Parkinson’s at 53, learned about My Angel My Hero in a chat room. In her video testimonial she says: “Every day I wake up, and I have a sense of gratitude. I hope that as my Parkinson’s gets worse and as I meet each new challenge, I continue to have an attitude of thankfulness and a choice to be happy.”
About My Angel My Hero
My Angel My Hero is a 501(3)(c) non-profit organisation committed to raising awareness for various social, medical and charitable causes including Parkinson’s disease, autism and domestic violence. What began as an idea to help patients tell their stories has grown into a full team of volunteers and community members that is rooted in compassion, growth and advocacy.
Thank you, Parkinson’s disease: 10 reasons to be grateful this Thanksgiving
There's a lot to thank Parkinson's for, says blogger 'Twitchy Woman'
4 days ago
Parkinson’s gene therapy could improve motor symptoms
UK researchers are trialling an innovative gene therapy that could improve motor symptoms – such as tremors and rigidity – experienced by people with Parkinson’s. The therapy, named AXO-Lenti-PD, has been developed by biopharmaceutical companies Oxford BioMedica and Axovant Sciences. The trial will work with 30 participants living with Parkinson’s at hospitals in London and Cambridge, UK and Paris, France. The first stage will evaluate the safety and dosage of the therapy – and the second stage will assess the long-term effects of the therapy on motor function. Professor Thomas Foltynie, neurology consultant at University College London Hospitals – which is carrying out the research alongside University College London – said: “Genes that increase the production of dopamine could help alleviate the symptoms of Parkinson’s disease, potentially with fewer side effects than traditional drug treatments, by targeting only the areas of the brain that are lacking in dopamine.”
Pfizer launches new biopharmaceutical company to develop Parkinson’s drugs
Pharmaceutical company Pfizer has teamed with investment firm Bain Capital to launch Cerevel Therapeutics – a biopharmaceutical company focused on developing drugs for Parkinson’s and other central nervous system conditions. The new company – which will receive US $350 million of investment from Bain Capital – will begin working on phase three clinical trials on a Parkinson’s drug designed to increase levels of dopamine in the brain. Cerevel will also continue to develop several of Pfizer’s drug programmes which closed earlier this year. Marco Baptista, director of research programmes at The Michael J Fox Foundation – which has partnered with Pfizer since 2010 – said: “This is welcome news for Parkinson’s patients and researchers. Pfizer had developed a diverse group of novel therapeutics for Parkinson’s disease, which are now going to get another chance at success. MJFF looks forward to partnering with Cerevel to support the advancement of these promising…
AI technology could diagnose Parkinson’s in less than three minutes
Chinese technology enterprise Tencent has partnered with UK healthcare company Medopad and the Centre of Excellence in Parkinson’s and Movement Disorders at Kings College Hospital, UK, to create artificial intelligence (AI) software that may be able to diagnose Parkinson’s in less than three minutes. The team trained the AI system by analysing video footage of people with Parkinson’s, and believes it will help doctors identify and diagnose the condition at a far earlier stage. In addition, it is hoped the test could be carried out remotely using smartphone technology. Dan Vahdat, CEO and Co-founder of Medopad, said: “Our partnership with Tencent comes from a shared vision to change the future of healthcare as we know it. “In combining Medopad’s medical expertise and Tencent’s technical capabilities, we hope to provide the technology needed to support clinicians to predict preventable complications for people with Parkinson’s disease.”